Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Epilepsy, Date of authorisation: 29/08/2008, Revision: 46, Status: Authorised

Product-information requirements

Risk management

Draft guideline on VICH GL60 Good manufacturing practice for active ingredients used in veterinary medicinal products

Paediatric medicines: Marketing authorisation

Medicines for use outside the European Union

VICH GL60 Good manufacturing practice for active ingredients used in veterinary medicinal products - Scientific guideline

FAQs: How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10

Clinical Trial Information System (CTIS) - Sponsor handbook

Hycamtin (topotecan) supply shortage